BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37905433)

  • 1. Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient.
    Wang N; Yu C; Wang W; Yang Q
    J Dermatolog Treat; 2023 Dec; 34(1):2276044. PubMed ID: 37905433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease.
    Hurabielle C; Schneider P; Baudry C; Bagot M; Allez M; Viguier M
    J Dermatolog Treat; 2016; 27(1):67-9. PubMed ID: 25909366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extensive ulcerations in children: The difficulty diagnosing pyoderma gangrenosum].
    Ramli I; Rachadi H; Amarouch H; Rimani M; Senouci K; Benzekri L; Hassam B
    Arch Pediatr; 2015 Jul; 22(7):753-5. PubMed ID: 26047747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum following trauma of the knee: a case of pathergy and review of orthopaedic cases.
    Steenbrugge F; Raaijmaakers M; Caekebeke P; Van Landuyt K
    Injury; 2011 Apr; 42(4):421-3. PubMed ID: 20638661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum.
    Vieira WA; Barbosa LR; Martin LM
    An Bras Dermatol; 2011; 86(6):1193-6. PubMed ID: 22281912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A no scarring persistent skin lesion for 3 years pyoderma gangrenosum].
    Ndour MA; Sow D; Diedhiou D; Senghor F; Diembou M; Diouf M; Faye A; Diallo IM; Barrage AL; Kabou LM; Mbaye MN; Sarr A
    Pan Afr Med J; 2019; 32():198. PubMed ID: 31312310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Pyoderma Gangrenosum.
    Tan MG; Tolkachjov SN
    Dermatol Clin; 2024 Apr; 42(2):183-192. PubMed ID: 38423680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum.
    Goldust M; Hagstrom EL; Rathod D; Ortega-Loayza AG
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):157-161. PubMed ID: 31875484
    [No Abstract]   [Full Text] [Related]  

  • 10. Certolizumab for the treatment of localized pyoderma gangrenosum associated with Crohn's disease: A case report.
    Pender TM; Ayandibu G; Van Voorhees AS
    Dermatol Ther; 2020 Nov; 33(6):e14352. PubMed ID: 32981217
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum after minor trauma in a pregnant woman, mistaken for necrotizing fasciitis: report of a case and literature review.
    De Menezes D; Yusuf E; Borens O
    Surg Infect (Larchmt); 2014 Aug; 15(4):441-4. PubMed ID: 24476017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child.
    Kawabe S; Iwata N; Nishida E; Kohagura T; Abe N; Nakaseko H; Morita A
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):137-140. PubMed ID: 33016252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of treatments used in pyoderma gangrenosum.
    Feldman SR; Lacy FA; Huang WW
    Expert Opin Drug Saf; 2018 Jan; 17(1):55-61. PubMed ID: 29065721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum following gastric bypass surgery.
    Urman CO; Ashby-Richardson H; Thakker PS
    Cutis; 2014 May; 93(5):261-3. PubMed ID: 24897140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].
    Boulenger-Vazel A; Kupfer-Bessaguet I; Gouedard C; Leberre R; Leroy JP; Sonnet E; Desvignes O; Misery L; Sassolas B
    Ann Dermatol Venereol; 2005 Jan; 132(1):27-31. PubMed ID: 15746603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum.
    Conrad C; Trüeb RM
    J Dtsch Dermatol Ges; 2005 May; 3(5):334-42. PubMed ID: 16372799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile pyoderma gangrenosum: Successful treatment with thalidomide.
    Hu YQ; Yao XX; Zhang JZ; Li WH
    Dermatol Ther; 2019 Jul; 32(4):e12952. PubMed ID: 31025475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
    Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
    Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
    Shaath TS; Om A; Wolfe CM; Cohen GF
    J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.